Serialization a Key Focus in Developing Regions

Manufacturers face global challenges implementing serialization standards, according to a report by PMMI Business Intelligence.

Jun 22nd, 2018
Serialization a key focus in developing regions
Serialization a key focus in developing regions

In addition to a high initial capital investment, one complexity of the pharmaceutical industry is the strict regulatory controls that make the sector challenging to thrive in and largely dominated by multinationals that have the resources to meet these requirements.

Manufacturers face many challenges with implementation, such as replacing legacy systems throughout the supply chain that are often inadequate for processing the large volume of data necessary for compliance. Additionally, the cost of meeting these standards is high, with some reporting that they have already invested upwards of $50 million on building the necessary capabilities for compliance.

  • The European Union Falsified Medicines Directive (FMD) outlines measures which include the need for serialization of packages to enable traceability of drugs throughout the supply chain. This includes the mandate that packaging must include 2D codes. The deadline for meeting the FMD legislation has been extended from the start of 2017 to the start of 2019 to allow companies to fully implement and comply. Despite Brexit, the United Kingdom still plans to comply with this legislation.

  • In Brazil, RDC 54, according to law 13.140/16, there will be several implementation deadlines leading up to the 2021 deadline requiring all products to be serialized and traced. Legislation around traceability is largely affecting this sector and is driving the labeling, coding and decorating machinery market to be one of the fastest growing.

  • The China Food and Drug Administration (CFDA) has been gradually implementing its Electronic Drug Monitoring Network since 2011, which is part of its plans to enable traceability of all drug products through the supply chain. In July 2016, the CFDA released an update that it would be revising the pharmaceutical quality management specification, alluding to future serialization requirements.

Source: PMMI Business Intelligence, “Global Trends Impacting the Market for Packaging Machinery 2018.” Download the FREE full report here.

Fda Logo, Hi Res
FDA Holding Webinar on Animal Drug Manufacturing System eSubmitter Tool
The session will provide information about new enhancements to the system used to support the creation of electronic, secure submissions to the FDA’s Center for Veterinary Medicine for review.
Jun 20th, 2022
2022 Pdafda Linkedin
2022 PDA/FDA Joint Regulatory Conference
Hosted by the Parenteral Drug Association (PDA), the conference takes place Sep 12 - Sep 14, 2022 in Washington D.C.
Jun 3rd, 2022
Abbott Elecare
FDA Flexibilities to Yield Millions of Cans of Additional Infant Formula
In the coming months, the FDA will be able to greatly increase the supply of formula, including Abbott EleCare, available to U.S. consumers through international and domestic manufacturing facilities.
May 26th, 2022
Fda Logo, Hi Res
FDA Releases White Paper on Quality Management Maturity
The new white paper discusses developing a framework to evaluate the QMM of pharmaceutical manufacturing sites and the benefits of a rating system.
May 23rd, 2022
At the[PACK]out, presenting 'Wicked Stability: Predicting the Aging Degradation of Materials' were speakers (from left): Dan Burgess, Henk Blom, and Rod Patch w/ Moderator Seema Momin.
KiiP Tackles Wicked Problems in Package Material Stability
What began as a chat over coffee has led to work on a hypothesis and a white paper with far-reaching potential in saving time and resources in medical device packaging stability testing. Efforts were presented at the[PACK]out's inaugural event in Austin.
May 10th, 2022
Fda Logo, Hi Res
FDA Permits Marketing for Test to Improve Diagnosis of Alzheimer’s Disease
The Lumipulse test is intended to measure the ratio of β-amyloid 1-42 and β-amyloid 1-40 concentrations found in human cerebral spinal fluid.
May 6th, 2022
Elon
the[PACK]out:  Supply Chain - Navigating Disruptions
EXPERIENCE the[PACK]out: Created for industry professionals, by industry professionals.
Apr 26th, 2022
Fda Logo, Hi Res
FDA Issues New Guidance to Increase Racial and Ethnic Diversity in Clinical Trials
The agency’s focus on inclusion in trials for all medical products aligns with Biden Administration’s Cancer Moonshot goal of addressing inequities and beyond.
Apr 22nd, 2022
Fda Logo, Hi Res
Cybersecurity in Medical Devices: FDA Announces New Draft Guidance
The new guidance deals with quality system considerations and the content of premarket submissions for members of the medical device industry, as well as Food and Drug Administration staff.
Apr 15th, 2022
Speakers from left at TempPack: Mark Maurice, Sensitech; Eric Silberstein, eBiotech Consulting, LLC; Bryan Cardis, Eli Lilly and Company; Arif Rahman, MaxQ Research LLC
10 Temperature Monitor Qualification Considerations
From the 2022 ISTA Forum TempPack: Panelists discussed the latest on temperature recording device (TRD) qualification, including dry ice and LCD screens, probes that disconnect, and what to consider before selecting a shipper integrated with a TRD.
Apr 15th, 2022
Fda Logo, Hi Res
FDA Recommends Use of Duodenoscopes With Innovative Designs to Enhance Safety
The agency is providing new information supporting the transition to fully disposable duodenoscopes and those with disposable components, as well as new information on completed post-market surveillance studies.
Apr 8th, 2022
Hcp Title
Solution for Expiry Labels, DtP, and Study Timelines Due to EU 536/2014 Clinical Trials Regulation
The new regulation improves many aspects of clinical preparation and activation but brings certain new challenges for sponsors.
Mar 18th, 2022
Heuft Spotter Ii Phs
Full Vial Inspection: Simply Complete!
Unit carries out optical and radiometric inspection and volumetric determination of O2 content in the headspace
Mar 15th, 2022
Getty Images 1161368565
Future for Pharmaceutical Manufacturers Includes More Digitized Data Collection
While automation is driving physical changes to pharmaceutical production and packaging processes, another significant shift is occurring in the accumulation and use of data.
Mar 14th, 2022
Regulation EU No 536/2014 on clinical trials will come many changes that will impact study startup processes and timelines, expiry labeling on primary and secondary packaging, and study administration methods such as direct-to-patient.
Part 1: Manage Challenges from the EU 536/2014 Clinical Trials Regulation
Plan ahead for study startup timelines, expiry labeling on primary packaging solutions, and study administration methods.
Mar 10th, 2022
Pw 7643 Web Cargo
Tips for Exporting Goods in 2022
Live from Natural Products Expo West: An international trade expert discusses why you need to know your buyers, what you can ship to a sanctioned country, insurance for sea cargo, and more.
Mar 9th, 2022
Fda Logo
FDA Issues Voluntary Recalls Final Guidance
The guidance will help companies prepare to quickly and effectively remove violative products from the market, as the agency urges companies to be “recall ready” to protect public health.
Mar 4th, 2022
Recipharm Pic
Industry Reacts to FDA Draft Guidance on Injectable Products Inspection
Pharmaceutical companies and the International Society for Pharmaceutical Engineering want the FDA to align visible particle classifications and inspections with USP.
Mar 1st, 2022
Fda Logo
FDA Proposes Rule to Amend Medical Device CGMP Requirements
The proposed amendments to the CGMP requirements of the Quality System (QS) Regulation will align them more closely with the international consensus standard for devices.
Feb 28th, 2022
Fda Chief Robert Califf
New FDA Chief Confirmed by Senate
Dr. Robert Califf narrowly secures position again on a 50-46 vote, despite concerns over his pharmaceutical industry ties.
Feb 16th, 2022
More in Regulatory
Gao Logo 2
GAO Makes Recommendations to Improve FDA Foreign Inspection Program
Drugs manufactured overseas for the U.S. market must meet the same requirements as those manufactured in the U.S., raising questions about the equivalence of foreign to domestic inspections.
Feb 9th, 2022
Fda Logo
FDA Proposes Rule for Wholesale Drug Distributors, Third-party Logistics Providers
If passed, the rule would allow only those licensed according to the proposed national standards to engage in transactions related to the sale and distribution of certain prescription drugs with other members of the supply chain.
Feb 8th, 2022
Fda Logo
FDA Publishes Draft Guidance on Reporting Certain Medical Device Shortages
The new guidance helps clarify how the agency interprets 506J notification requirements, including when and who should submit a notification and the information that should be included.
Feb 1st, 2022
Safety
Safety in Aseptic Filling
FDA provides insight into common pitfalls found during inspections along with possible solutions.
Jan 21st, 2022
Fda Logo
FDA Releases Medical Devices Draft Guidance for Review
“The Transition Plan for Medical Devices Issued Emergency Use Authorizations During the Coronavirus Disease 2019 Public Health Emergency” guidance is now available for review.
Jan 12th, 2022
Aseptic processing is one of the highest risk pharmaceutical operations, and thus requires a high level of control.
Pitfalls to Avoid in FDA Aseptic Manufacturing Inspections
From personnel to facility design to process, FDA policy advisor provides an outline of what facilities can improve on.
Jan 5th, 2022
Serialization Master Data 60a571e0dae99
Counting Down the Top 10 Articles of 2021 - #1: Serialization 101
Join us as we look back at the most-read Healthcare Packaging stories of 2021. At #1, we’re going back to basics with an introductory look at serialization, required by pharma and medical device regulations to defend against counterfeiting.
Jan 4th, 2022
Getty Images 1208358564 6073d57fe5816
Counting Down the Top 10 Articles of 2021 - #4: Data and AI Accelerate Digital Transformation
Join us as we look back at the most-read Healthcare Packaging stories of 2021. At #4, we cover the growing need for pharma manufacturing facilities to become digitalized to improve productivity and make the most of the ‘digitally native’ workforce.
Dec 29th, 2021
Dscsa Getty
FDA Discusses Nov. 2023 DSCSA Future State
At the HDA Traceability Online Seminar (Nov. 1-3, 2021), FDA’s Connie Jung, RPh, talked about how DSCSA continues to transform the pharmaceutical supply chain to preserve drug safety and security.
Nov 30th, 2021
For product traceability, outbound scanning alone is expected to increase labor by a minimum of 12 to 15% based on recent time studies, per Cardinal Health.
Will Labor Requirements Increase in Meeting DSCSA Milestones?
With many companies either facing or concerned about labor shortages in manufacturing, an expert from Cardinal Health notes that outbound scanning alone may require a 12 to 15% increase in headcount in their operations.
Nov 18th, 2021
Companies are adopting robotics and biometrics initiatives in drug product manufacturing and modern, robust aseptic processing technologies that afford tangible safety benefits to sterile products.
Applying Modern Technology to Pharmaceutical Production Facilities
Robotics, biometrics, and isolator technology are proving cleaner, faster, and safer than traditional manual methods.
Nov 16th, 2021
Hp 107536 Surgical Tools Copy png 2
EU Regulators, Recycling, and Healthcare Plastics
Packaging suppliers speak about the openness of regulators to understand the slower nature of life science manufacturers in adopting more sustainable packaging.
Nov 11th, 2021